Wednesday, January 24, 2024 11:09:40 AM
nternal emails cited during the trial's opening statements on Jan. 9 showed that Google's now-chief scientist, Jeff Dean, wrote to others about how Bates' ideas could be "really well suited" for what Google was developing.
Google countered that the employees who designed its chips never met Bates and created them independently. The company said its technology was "fundamentally different than what is described in Singular's patents."
Recent NLST News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:31:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 02:30:15 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:54:43 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 02:44:15 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/01/2024 09:35:01 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/01/2024 09:32:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/19/2024 02:38:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/16/2024 02:52:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2023 12:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2023 01:30:09 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/06/2023 02:22:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/18/2023 08:30:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/16/2023 01:30:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2023 09:01:19 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/15/2023 09:00:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 12:00:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/11/2023 01:53:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:45:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 12:30:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/18/2023 01:30:27 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM